Please Wait...

Upcoming Webinar: How Improving Site Payments Can Make You the Sponsor/CRO of Choice

Join us for our upcoming webinar on June 27th where Lorie McClain, the VP of Product Management and Product Development and Technology at Bioclinica, Inc., and other Bioclinica clinical payments experts will present and discuss case studies illustrating how trial sponsors and CROs are becoming partners of choice at high-performing sites.

Timely and accurate payments for contracted activities by the sponsor or CRO to the clinical site are important considerations for sites when deciding which companies to do business with. This is particularly true given the increasing resource constraints under which investigative sites are operating.

Clinical payment solutions can help to:

  • Streamline and automate grant payments, replacing inefficient and error-prone manual processes with a fast and accurate data-driven process
  • Provide clear visibility to future payment forecasts for all stakeholders, sponsors, CROs and sites as well as reporting on payment trends
  • Free monitors to focus on core tasks instead of being forced to manage payment-related activities.

Furthermore, sponsors and CROs that implement these solutions benefit from increased control over study cash flow, improved operational efficiencies and better compliance.

The presented case studies will provide examples of the benefits of clinical payments solutions for sites, sponsors and CROs. To join us for this webinar and learn more, register here.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

"Mud run" 1 obstacle in vaccine trials w elderly. Here R 5 more & how to conquer by Dr. Craig Curtis… https://t.co/vIk4B2Howd
bioclinica (3 hours ago)
What's new in tech for ICH E6 R2 reqs for quality and #RBM? https://t.co/xsmNm8d35o #Pharma
bioclinica (6 hours ago)
Vaccine clinical trials: Boost senior participation following simple advice from Dr. Craig Curtis… https://t.co/OuTKyu0DPT
bioclinica (7 hours ago)
RT @ElisendaGendra: Decision on #EMA Relocation Set for November, Council Agrees on Bidding Procedure via @RAPSorg https://t.co/a42Eszg81o…
bioclinica (Yesterday)
@Xtalks Looking forward to tomorrow's webinar on site payments!
bioclinica (Yesterday)
Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (Yesterday)

Latest Blogs: